心脏骤停后[18F]FDG正电子发射断层扫描评估脑葡萄糖代谢
该研究在C57BL/6小鼠中经12分钟氯化钾诱导心脏骤停后行心肺复苏,于72小时后腹腔注射[18F]FDG(约186 µCi/200 µL)行micro-PET/CT显像。与假手术组和对照组相比,心脏骤停后小鼠全脑[18F]FDG摄取增高,中位数标准化摄取值1.79 vs 假手术组1.25(p<0.05)vs 对照组0.78(p<0.01),并在中脑、脑桥和延髓达到统计学显著。生物分布分析显示脑摄取中位数7.04%ID/g组织 vs 假手术组5.537%ID/g组织(p<0.05)。作者认为心脏骤停后72小时脑[18F]FDG摄取增加提示严重神经损伤时代谢需求增加,需进一步研究确定这些变化的病因。
要点
- 小鼠心脏骤停模型复苏后72小时全脑[18F]FDG摄取中位数1.79,高于假手术组1.25(p<0.05)和对照组0.78(p<0.01)。
- 摄取增高在60分钟显像期内持续存在,并在中脑、脑桥和延髓达到统计学显著。
- 生物分布分析脑摄取中位数7.04%ID/g组织 vs 假手术组5.537%ID/g组织(p<0.05)。
- 作者认为该结果提示严重神经损伤时代谢需求增加。
- 作者指出需进一步研究确定这些代谢变化的病因。
适用人群与场景
- 麻醉并机械通气的成年C57BL/6小鼠,经12分钟氯化钾诱导心脏骤停后行心肺复苏,72小时后存活者。
处置流程与药物剂量
- 心脏骤停后72小时存活小鼠腹腔注射[18F]FDG约186 µCi/200 µL,清醒摄取30分钟后在Molecubes临床前micro-PET/CT系统显像。
- PET显像结束后用伽马计数器测定脑、心脏和肝脏残余[18F]FDG放射性。
研究设计与关键结果
- 动物实验:成年C57BL/6小鼠经12分钟氯化钾诱导心脏骤停后心肺复苏,72小时后行[18F]FDG-PET/CT。
- 心脏骤停组[18F]FDG中位数标准化摄取值1.79 vs 假手术组1.25(p<0.05)vs 对照组0.78(p<0.01)。
- 摄取增高在60分钟显像期内持续存在,并在中脑、脑桥和延髓达到统计学显著。
- 生物分布分析脑摄取中位数7.04%ID/g组织(心脏骤停组)vs 5.537%ID/g组织(假手术组),p<0.05。
证据类型、等级与局限
- 证据类型:动物实验(小鼠心脏骤停模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为心脏骤停后72小时脑[18F]FDG摄取增加提示严重神经损伤时代谢需求增加。
- 作者指出需进一步研究确定这些代谢变化的病因。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac arrest (CA) patients who survived by cardiopulmonary resuscitation (CPR) can present different levels of neurological deficits ranging from minor cognitive impairments to persistent vegetative state and brain death. The pathophysiology of the resulting brain injury is poorly understood, and whether changes in post-CA brain metabolism contribute to the injury are unknown. Here we utilized [18F]fluorodeoxyglucose (FDG)-Positron emission tomography (PET) to study in vivo cerebral glucose metabolism 72 h following CA in a murine CA model.
METHODS: Anesthetized and ventilated adult C57BL/6 mice underwent 12-min KCl-induced CA followed by CPR. Seventy-two hours following CA, surviving mice were intraperitoneally injected with [18F]FDG (~ 186 µCi/200 µL) and imaged on Molecubes preclinical micro-PET/computed tomography (CT) imaging systems after a 30-min awake uptake period. Brain [18F]FDG uptake was determined by the VivoQuant software on fused PET/CT images with the 3D brain atlas. Upon completion of Positron emission tomography (PET) imaging, remaining [18F]FDG radioactivity in the brain, heart, and liver was determined using a gamma counter.
RESULTS: Global increases in brain [18F]FDG uptake in post-CA mice were observed compared to shams and controls. The median standardized uptake value of [18F]FDG for CA animals was 1.79 versus sham 1.25 (p < 0.05) and control animals 0.78 (p < 0.01). This increased uptake was consistent throughout the 60-min imaging period and across all brain regions reaching statistical significance in the midbrain, pons, and medulla. Biodistribution analyses of various key organs yielded similar observations that the median [18F]FDG uptake for brain was 7.04%ID/g tissue for CA mice versus 5.537%ID/g tissue for sham animals, p < 0.05).
CONCLUSIONS: This study has successfully applied [18F]FDG-PET/CT to measure changes in brain metabolism in a murine model of asystolic CA. Our results demonstrate increased [18F]FDG uptake in the brain 72 h following CA, suggesting increased metabolic demand in the case of severe neurological injury. Further study is warranted to determine the etiology of these changes.
参考来源
- Zhang HJ, Mitchell S, Fang YH, et al. Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [18F]FDG Positron Emission Tomography. Neurocrit Care. 2021. PMID: 32358767. doi:10.1007/s12028-020-00984-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。